{"schema_version":"secwatch.filing_event.v1","accession":"0000097745-23-000054","form_type":"8-K","ticker":"TMO","cik":"0000097745","company_name":"THERMO FISHER SCIENTIFIC INC.","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.123889+00:00","generated_at":"2026-06-13T02:41:40.781744+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Thermo Fisher Q2 revenue $10.69B (-3% YoY), GAAP EPS $3.51, cuts FY guidance","bullets":["Q2 revenue $10.69B, down 3% YoY; core organic growth +2%; COVID testing revenue $0.08B.","GAAP diluted EPS $3.51 (vs $4.22 YoY); adjusted EPS $5.15 (vs $5.51 YoY).","FY 2023 guidance revised: revenue $43.4-44.0B, core organic growth 2-4%, adj. EPS $22.28-22.72.","Announced agreement to acquire CorEvitas for ~$0.9B post-quarter; adds real-world evidence solutions.","CEO cites challenging macro, slower China spend; PPI Business System helping navigate environment."],"urls":{"canonical":"https://secwatch.observer/filing/0000097745-23-000054","json":"https://secwatch.observer/filing/0000097745-23-000054.json","markdown":"https://secwatch.observer/filing/0000097745-23-000054.md","text":"https://secwatch.observer/filing/0000097745-23-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/97745/000009774523000054/0000097745-23-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/97745/000009774523000054/tmo-20230726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:41:40.781744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"deeed189a9e982f06511ffdd9a34ff19cecf1507","claim":"THERMO FISHER SCIENTIFIC INC. reported the fiscal quarter ended July 1, 2023 results: revenue $10.69 billion, EPS $3.51. Guidance lowered.","evidence_excerpt":"the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023. Second Quarter 2023 Highlights • Second quarter revenue was $10.69 billion, 3% lower versus the same quarter last year. Core organic revenue growth was 2%. • Second quarter GAAP diluted earnings per share (EPS) was $3.51. • Second quarter adjusted EPS","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/97745/000009774523000054/0000097745-23-000054-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended July 1, 2023"},{"label":"Revenue","value":"$10.69 billion"},{"label":"EPS","value":"$3.51"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}